Based in South Africa, Next Biosciences is a unique company. It owns Netcells, Africa’s largest private stem cell bank. It also recently merged with a local laboratory, Genesis Genetics, making Next Biosciences the only facility on the African continent to offer genetic and metabolic screening, as well as storage of umbilical cord blood and tissue for use in regenerative medicine applications.
As such, Next Biosciences plays a leading role within the South African cord blood banking marketplace and operates within genetic and metabolic screening markets.
To learn more about Next Biosciences and its recent merger with Genesis Genetics South Africa, read the company press release below, printed with permission from the company’s Public Relations advisor, Gina de Villiers.
Next Biosciences and Genesis Genetics South Africa Combine their DNA
Merger of local leaders in stem cell banking and genetic testing consolidate their position
in African biotechnology industry
Johannesburg, 17 May 2016 — Next Biosciences, a South African leader in stem cell banking, and Genesis Genetics South Africa, the local provider of internationally pioneered genetic technology, have merged to consolidate their position in South Africa’s burgeoning biotechnology industry. As a result, Genesis Genetics South Africa becomes a Next Biosciences company.
The new Next Biosciences group of companies owns Netcells, Africa’s largest private stem cell bank. This is now the only such facility on the continent to offer genetic and metabolic screening as well as storage of umbilical cord blood and tissue for use in various regenerative medical therapies. [Read more…]
